id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0510-0012,FDA,FDA-2009-E-0510,Determination of Regulatory Review Period for Purposes of Patent Extension: COARTEM,Notice,N-Notice,2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2024-11-07T22:28:12Z,2010-31074,1,0,0900006480bb3967
FDA-2009-E-0510-0011,FDA,FDA-2009-E-0510,U.S. Patent and Trademark Office to the FDA/CDER - Letter,Other,LET-Letter,2010-04-21T04:00:00Z,2010,4,2010-04-21T04:00:00Z,,2013-07-27T23:16:24Z,,0,0,0900006480adc3e7
FDA-2009-E-0510-0008,FDA,FDA-2009-E-0510,FDA/CDER to U.S. Patent  and Trademark Office - Letter,Other,LET-Letter,2010-02-18T05:00:00Z,2010,2,2010-02-18T05:00:00Z,,2013-07-27T23:08:47Z,,0,0,0900006480aa72bb
FDA-2009-E-0510-0010,FDA,FDA-2009-E-0510,Novartis - Supplemental Patent Term Extension Application,Other,APP-Application,2010-02-18T05:00:00Z,2010,2,2010-02-18T05:00:00Z,,2013-07-27T23:04:49Z,,0,0,0900006480a80810
FDA-2009-E-0510-0009,FDA,FDA-2009-E-0510,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-02-18T05:00:00Z,2010,2,2010-02-18T05:00:00Z,,2013-07-27T23:04:49Z,,0,0,0900006480a8080e